PiggyGPT

Private companiesCovered

Coefficient Bio

New York, NY · Founded 2025

Coefficient Bio, founded by former Genentech researchers, used AI for drug discovery and biological research; it was in stealth with no public product.

Funding

Last round or tender
—
Last valuation
No citable valuation

Secondary venues

No public venue page on file.

A venue is listed when its public page named the company on the date shown. Nothing is recorded from behind a login, and no indicative price is shown anywhere on this site.

Reads

Acquisition: Closed

The acquisition completed.

Prepared by PiggyGPT, as of Oct 7, 2026

Signals

  • Apr 3, 2026TechCrunch relayed reports by The Information and Eric Newcomer of a $400 million stock deal; sources confirmed to TechCrunch that it closed and declined to comment on the amount. No company announcement was found.TechCrunch, Apr 3, 2026

Named counterparties

  • AnthropicThe acquirer, by the reports TechCrunch relayed and confirmed as closed.TechCrunch, Apr 3, 2026

Counterparties are named for a cited reason: a partnership, an investment, or a stated appetite. Naming is not a forecast.

A summary of what the figures on this page add up to, prepared by PiggyGPT from the record on file and its cited sources. Not the Street's view, and not advice.

Sources

Researched Oct 7, 2026